Bryan McIver

  • Dr. McIver received his MB ChB degree from the University of Edinburgh Medical School in Scotland, following undergraduate work in Edinburgh and a PhD in Physiology and Biophysics at the University of Vermont. He completed an Internal Medicine Residency at the Royal Infirmary of Edinburgh, followed by a Clinical Fellowship and Clinical Investigator Fellowship in Endocrinology at the Mayo Graduate School of Medicine in Rochester, MN.

    Dr. McIver joined the staff of Mayo Clinic in 1998 and spent 15 years as a Consultant in Endocrinology and Internal Medicine at the Mayo Clinic and Foundation, with 5 of those years as Chairman of the Mayo Clinic Thyroid Group. He was appointed as a founder member of the Endowed and Master Clinician Program at the Mayo Clinic in Rochester, Minnesota, in 2011, recognizing excellence in patient care.  In 2013, he moved to Moffitt Cancer Center, to become the Program Leader of the Endocrine Tumor Program.  His success in Leadership and team-building led to his appointment as Founding Chair of Moffitt’s newly created Department of Head and Neck, and Endocrine Oncology.  He additionally assumed the role of Interim Chair of the Department of Breast Oncology, pending recruitment of a new permanent Department Chair. Subsequently, in 2015, he was appointed Deputy Physician in Chief of the Moffitt Medical Group.

    Dr. McIver maintains an active busy practice, focused exclusively on patients with Thyroid Nodules and Thyroid Cancer; is active in research on molecular diagnostics, prognostics and therapeutics, and collaborates on clinical trial development in Thyroid Cancer, using targeted therapies, adaptive strategies and evolutionary principles; and he remains engaged in education of Fellows, Residents and Medical Students, having received two Mayo Clinic “Teacher of the Year” awards, recognizing his commitment to education.

    Dr McIver is a founding member of the World Congress on Thyroid Cancer, a quadrennial International meeting, now the largest such meeting in the World.  Amongst his most proud accomplishments was the creation of the Department of Head and Neck – Endocrine Oncology at Moffitt Cancer Center, now recognized as a World leader in the management of patients with thyroid cancer and other Endocrine malignancies.

     

 

Leave a Reply

  • Upcoming Events

     

    World Congress on Thyroid Cancer 3.5
    June 20 – 22, 2019
    Rome, Italy

    World Congress on Thyroid Cancer 4.0
    July 29 – August 1, 2021
    Boston, Massachusetts

     

  • WCTC3.5 Steering Committee:

     

    Rocco Bellatone, Co-Chair
    Celestino Lombardi, Co-Chair
    Gregory W. Randolph, MD
    Bryan McIver, MD
    Jeremy Freeman, MD
    Ian J. Witterick, MD
    Ashok R. Shaha, MD
    Jatin P. Shah, MD